AMLODIPINE-OLMESARTAN 10-40 MG

Amlodipine besylate and Olmesartran medoxomil
$0.3533per EA

Strength

10; 40 mg/1; mg/1

NDC

62332021590

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207073

On Market Since

7/18/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price History

1W

0.0%

1M

+0.1%

3M

+0.2%

6M

+11.9%

1Y

+3.6%

3Y

N/A

5Y

N/A

All

-8.8%